Cardiovascular disease (CVD) is Australia’s leading cause of death, but our diagnostic methods are flawed. Data are emerging for new technology - dynamic chemical imaging (DCI) – which combines artificial intelligence, laser beams and non-harmful radiation to provide diagnoses in real time. Dr Sharma and team, plan to build and validate this technology for CVD: in particular diagnosing heart damage, weak sternums and irregular heart rhythms, with life-saving potential for more than 1 million Australians diagnosed CVD each year.
This will involve:
(a) building a DCI probe that can be used clinically
(b) validating it on high-risk cardiovascular tissue- Heart tissue
(c) Assessing its impact on cardiac surgery
Last updated05 April 2022